We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 63

EPO Enlarged Board of Appeal rejects patent that requires human embryos for implementation

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • December 31 2008

In its decision of 25 November 2008 the EPO Enlarged Board of Appeal (EBA) considered four questions referred to it by the EPO Technical Board of Appeal concerning a patent application by Wisconsin Alumni Research Foundation (WARF) with claims to “a cell culture comprising primate embryonic stem cells…”

Paedriatric SPC extension: zero or negative term SPCs

  • Bird & Bird
  • -
  • European Union, United Kingdom
  • -
  • March 11 2009

Zero or negative term SPCs give rise to a unique disunity amongst the granting authorities in the European Member States

New regulatory requirements in the pharmaceutical sector

  • Bird & Bird
  • -
  • European Union
  • -
  • October 30 2008

Regulation (EC) No 19012006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use (hereinafter, “the Paediatric Regulation”) is intended to tackle the problems resulting from the absence of suitably adapted medicinal products for the paediatric population (including inadequate dosage information, non-availability to the paediatric population of therapeutic advances, suitable formulations and routes of administration as well as use of magistral or officinal formulations to treat the paediatric population

Patents Court judgment in Ratiopharm GmbH and Sandoz Limited v Napp Pharmaceutical Holdings Limited

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • March 11 2009

The Patents Court (Mr Justice Floyd) handed judgment down on 16 December 2008 relating to two patents regarding formulations to achieve slow release of the opioid pain killing drug, oxycodone

UK Patents Court judgment in Dr Reddy’s Laboratories v Eli Lilly

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • December 31 2008

In a judgment handed down in October of this year, the Patents Court (Mr Justice Floyd) upheld EP (UK) 0,454,436 (the “Patent”) which is owned by Eli Lilly and which protects the schizophrenia drug olanzapine

Leo v Sandoz UK Patents Court finds pseudopolymorph patent valid

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • July 17 2009

In his judgment of 15 May 2009 Mr Justice Floyd considered novelty and obviousness attacks on Leo Pharma’s European Patent (UK) 0,679,154 directed to the monohydrate pseudopolymorph of the vitamin D analogue calcipotriol, which is used in the topical treatment of psoriasis

Patent decisions on patents for chiral compounds

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • May 13 2009

A chiral compound is one which has at least one asymmetric carbon centre

Patent settlements under the authorities’ magnifying glass

  • Bird & Bird
  • -
  • European Union
  • -
  • December 15 2009

Drug prices are currently a key area of discussion in many countries around the globe

Edwards Lifesciences AG v Cook Biotech Incorporated

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • July 17 2009

Mr Justice Kitchin handed down a decision only four weeks after the hearing, finding Cook’s patent invalid and not infringed by Edwards’ SAPIEN heart valve

ECJ decision in AHP Manufacturing BV v the Bureau voor de Industriele Eigendom (Case C-48207)

  • Bird & Bird
  • -
  • European Union
  • -
  • October 13 2009

The ECJ has accepted that the holder of a basic patent is entitled to one SPC regardless of whether other SPCs have already been granted to other holders of one or more other basic patents